Stephen L. Silvestro - Mar 1, 2024 Form 4/A Insider Report for OptimizeRx Corp (OPRX)

Role
Chief Commercial Officer
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Stock symbol
OPRX
Transactions as of
Mar 1, 2024
Transactions value $
-$9,123
Form type
4/A
Date filed
5/6/2024, 09:34 PM
Date Of Original Report
Mar 6, 2024
Previous filing
May 6, 2024
Next filing
Apr 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Options Exercise $0 +1.93K +11.4% $0.00 18.8K Mar 1, 2024 Direct F1, F2
transaction OPRX Common Stock Tax liability -$9.12K -572 -3.04% $15.95 18.3K Mar 1, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
F2 A prior Form 4 filed by the Reporting Person failed to carry-forward previously owned shares, resulting in an understatement of the shares beneficially owned by the Reporting Person. The total amount beneficially owned has been adjusted to correct such inadvertent understatement.
F3 These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. The original Form 4 filed by the Reporting Person reporting this transaction overstated the number of shares withheld by the Issuer.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.